| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/17/2006 | US20060183200 Methods and means relating to protein variants |
| 08/17/2006 | US20060183199 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183190 Novel transporter protein |
| 08/17/2006 | US20060183189 Regulatable gene expression in mammalian cells and mammals |
| 08/17/2006 | US20060183188 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 08/17/2006 | US20060183187 Gene and polypeptide sequences |
| 08/17/2006 | US20060183186 Gene expression profiles in stomach cancer |
| 08/17/2006 | US20060183164 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 08/17/2006 | US20060183163 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183137 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 08/17/2006 | US20060183129 Isolated DNAs encoding the enzyme I-SpomI and its recognition and cutting site; useful in gene mapping and site-directed insertion of genes |
| 08/17/2006 | US20060183127 Use of silver gene for the authenication of the racial origin of animal populations and of the derivative products thereof |
| 08/17/2006 | US20060183123 Polymerase-based protocols for the introduction of combinatorial deletions... |
| 08/17/2006 | US20060183121 Chimeric autoprocessing polypeptides and uses thereof |
| 08/17/2006 | US20060183118 Nucleic acid recovery chip and nucleic acid recovery device |
| 08/17/2006 | US20060183114 Novel Eosinophil Cationic Proteins used in the Treatement of Asthematic and Allergic Disorders |
| 08/17/2006 | US20060183113 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
| 08/17/2006 | US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum |
| 08/17/2006 | US20060182762 Enterovirus, vaccines, medicaments and diagnostic kits |
| 08/17/2006 | US20060182760 Method for protecting living body from external factor and composition therefor |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182756 Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182754 Abundant extracellular products and methods for their production and use |
| 08/17/2006 | US20060182752 Tri-block polymers for nanosphere-based drug or gene delivery |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |
| 08/17/2006 | US20060182719 administering a nucleic acid encoding Ebp1 protein for suppressing or slowing the growth of prostate cancer; delivery a lentiviral vector biodrug as anticarcinogenic agent |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182717 Vector for expressing alpha-N-acetyl-galactosaminidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/17/2006 | DE10133844B4 Verfahren und Vorrichtung zur Detektion von Analyten Method and apparatus for detection of analytes |
| 08/17/2006 | CA2599036A1 Replication-deficient rna viruses as vaccines |
| 08/17/2006 | CA2597742A1 Transgenic plant for detecting environmental chemicals |
| 08/17/2006 | CA2597573A1 Method for the isolation of nucleic acids |
| 08/17/2006 | CA2597512A1 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof |
| 08/17/2006 | CA2597499A1 Fermentive vitamin c production |
| 08/17/2006 | CA2597482A1 Method for isolating nucleic acids comprising the use of ethylene glycol multimers |
| 08/17/2006 | CA2597462A1 Novel microbial enzymes and their use |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2597270A1 Methods and means for determining and conferring stress tolerance in plants |
| 08/17/2006 | CA2597225A1 Novel omega-3 fatty acid desaturase family members and uses thereof |
| 08/17/2006 | CA2596925A1 Method for improving expression level and stability of antibody |
| 08/17/2006 | CA2596832A1 Stable and long-lasting sirna expression vectors and the applications thereof |
| 08/17/2006 | CA2596600A1 Expression cassettes for regulation of expression in monocotyledonous plants |
| 08/17/2006 | CA2595495A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | CA2595395A1 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 08/17/2006 | CA2594834A1 Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products |
| 08/17/2006 | CA2571593A1 Antisense antibacterial method and compound |
| 08/16/2006 | EP1691197A2 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 08/16/2006 | EP1690949A1 Variant of HNF-1alpha gene having a single nucleotide polymorphism and variant of protein encoded by the same |
| 08/16/2006 | EP1690948A2 Methylation specific detection |
| 08/16/2006 | EP1690947A2 Base sequence for control probe and method of designing the same |
| 08/16/2006 | EP1690945A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 08/16/2006 | EP1690943A1 Modified plants |
| 08/16/2006 | EP1690942A1 Tetracycline-controlled insertion element for systematic mutagenesis |
| 08/16/2006 | EP1690941A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 08/16/2006 | EP1690940A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/16/2006 | EP1690939A2 Novel G protein-coupled receptor proteins |
| 08/16/2006 | EP1690938A1 Method for isolating nucleic acids, wherein the nucleic acids are immobilised on a matrix at elevated temperatures |
| 08/16/2006 | EP1690937A1 Method of constructing transgenic dendritic cell |
| 08/16/2006 | EP1690936A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690932A1 Bone and/or joint disease-associated gene |
| 08/16/2006 | EP1690927A1 Natural killer cell lines and methods of use |
| 08/16/2006 | EP1690875A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690868A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/16/2006 | EP1690548A2 Cell cycle progression proteins |
| 08/16/2006 | EP1690547A1 Prevention and treatment of amyloidogenic disease |
| 08/16/2006 | EP1690544A2 Pharmaceutical composition containing decoy and method of using the same |
| 08/16/2006 | EP1690093A2 Spherical and magnetic silicagel carriers having an increase surface for purifying nucleic acids |
| 08/16/2006 | EP1689890A2 Diagnostic tests for the detection of motor neuropathy |
| 08/16/2006 | EP1689888A2 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 08/16/2006 | EP1689886A1 Molecular marker associated with cmv resistance and use thereof |
| 08/16/2006 | EP1689873A2 Lactic acid producing yeast |
| 08/16/2006 | EP1689872A1 Promoters for expression in modified vaccinia virus ankara |
| 08/16/2006 | EP1689871A2 Controlling gene expression in plastids |
| 08/16/2006 | EP1689870A2 Improved targeted dna insertion in plants |
| 08/16/2006 | EP1689869A2 Recombinant microorganism |
| 08/16/2006 | EP1689868A1 Expression system for the b subunit of cholera toxin |
| 08/16/2006 | EP1689866A2 Msp-3-like family of genes |
| 08/16/2006 | EP1689865A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 08/16/2006 | EP1689864A2 Method and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions |
| 08/16/2006 | EP1689863A1 Template fixed beta-hairpin loop mimetics and their use in phage display |
| 08/16/2006 | EP1689862A2 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene |
| 08/16/2006 | EP1689849A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/16/2006 | EP1689786A2 Methods and agents for immune modulation and methods for identifying immune modulators |
| 08/16/2006 | EP1689784A2 Self-cleaving ribozymes and uses thereof |
| 08/16/2006 | EP1689783A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2006 | EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof |
| 08/16/2006 | EP1689766A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |